SEC Comment Letter for ACUSPHERE INC (CIK 0001115143) — Sep 20, 2004
ACUSPHERE INC (CIK 0001115143)
Date: Sept. 20, 2004 · CIK: 0001115143 · Accession: 0000000000-04-030183
AI Filing Summary & Sentiment
File numbers found in text: 333-119027
Show Raw Text
<DOCUMENT>
<TYPE>LETTER
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
Mail Stop 0309
September 20, 2004
Sherri C. Oberg
President and Chief Executive Officer
Acusphere, Inc.
500 Arsenal Street
Watertown, Massachusetts 02472
Re: Acusphere, Inc.
Registration Statement on Form S-1
File No. 333-119027, filed September 15, 2004
Dear Ms. Oberg:
This is to advise you that we have limited our review of the above-
captioned filing to the matters identified in the comments that
follow.
Where indicated, we think you should revise your filing in response
to our comments. If you disagree, we will consider your explanation
as to why our comments are inapplicable or a revision is unnecessary.
Please be as detailed as necessary in your explanation. In some of
our comments, we may ask you to provide us with supplemental
information so we may better understand your disclosure. After
reviewing this information, we may or may not raise additional
comments.
Please understand that the purpose of our review process is to assist
you in your compliance with the applicable disclosure requirements
and to enhance the overall disclosure in your filing. We look
forward to working with you in these respects. We welcome any
questions you may have about our comments or on any other aspect of
our review. Feel free to call us at the telephone numbers listed at
the end of this letter.
Selling Stockholders, page 71
1. If any selling stockholder is a broker-dealer, the prospectus must
state that such holder is an underwriter. The only exception to this
requirement is the situation where securities are issued to a broker-
dealer as compensation for underwriting activities. Please identify
in this section those selling stockholders, if any, who are broker-
dealers and revise the prospectus as necessary here and in the Plan
of Distribution section to disclose their status as underwriters.
2. In addition, if a selling stockholder is an affiliate of a broker-
dealer, the prospectus must state that:
? the selling stockholder purchased in the ordinary course of
business; and
? at the time of the purchase of the securities to be resold, the
selling stockholder had no agreement or understandings, directly or
indirectly, with any person to distribute the securities.
Please revise the prospectus as appropriate to identify those selling
stockholders who are affiliates of a broker-dealer and make the
required statements noted above. If you are not able to make these
statements about a given selling stockholder, you must state in this
section and in the Plan of Distribution section that such selling
stockholder is an underwriter.
Plan of Distribution, page 75
3. Please supplementally confirm that to the extent you become aware
that any selling stockholders did acquire its shares in the ordinary
course of business or, at the time of purchase of the securities, did
have an agreement or understanding, directly or indirectly, with any
person to distribute the securities, you will file a post-effective
amendment to this registration statement to designate such affiliate
as an "underwriter" within the meaning of the Securities Act
* * * * *
As appropriate, please amend your registration statement in response
to these comments. You may wish to provide us with marked copies of
the amendment to expedite our review. Please furnish a cover letter
with your amendment that keys your responses to our comments and
provides any requested supplemental information. Detailed cover
letters greatly facilitate our review. Please file your cover letter
on EDGAR under the form type label CORRESP. Please understand that
we may have additional comments after reviewing your amendment and
responses to our comments.
We urge all persons who are responsible for the accuracy and adequacy
of the disclosure in the filings reviewed by the staff to be certain
that they have provided all information investors require for an
informed decision. Since the company and its management are in
possession of all facts relating to a company`s disclosure, they are
responsible for the accuracy and adequacy of the disclosures they
have made.
Notwithstanding our comments, in the event the company requests
acceleration of the effective date of the pending registration
statement, it should furnish a letter, at the time of such request,
acknowledging that:
* should the Commission or the staff, acting pursuant to delegated
authority, declare the filing effective, it does not foreclose the
Commission from taking any action with respect to the filing;
* the action of the Commission or the staff, acting pursuant to
delegated authority, in declaring the filing effective, does not
relieve the company from its full responsibility for the adequacy and
accuracy of the disclosure in the filing; and
* the company may not assert this action as a defense in any
proceeding initiated by the Commission or any person under the
federal securities laws of the United States.
In addition, please be advised that the Division of Enforcement
has access to all information you provide to the staff of the
Division of Corporation Finance in connection with our review of your
filing or in response to our comments on your filing.
We will consider a written request for acceleration of the
effective date of the registration statement as a confirmation of the
fact that those requesting acceleration are aware of their respective
responsibilities under the Securities Act of 1933 and the Securities
Exchange Act of 1934 as they relate to the proposed public offering
of the securities specified in the above registration statement. We
will act on the request at the appropriate time and, pursuant to
delegated authority, grant acceleration of the effective date once
you have complied with any and all outstanding comments.
We direct your attention to Rules 460 and 461 regarding
requesting acceleration of a registration statement. Please allow
adequate time after the filing of any amendment for further review
before submitting a request for acceleration. Please provide this
request at least two business days in advance of the requested
effective date.
Please contact Jennifer Rawert, Attorney Adviser at (202) 824-5309 or
me at (202) 942-1840 with any questions.
Sincerely,
Jeffrey
Riedler
Assistant Director
cc: Lawrence S. Wittenberg, Esq.
Testa, Hurwitz & Thibeault, LLP
125 High Street
Boston, Massachusetts 02110
Sherri C. Oberg
Acusphere, Inc.
September 20, 2004
Page 1
</TEXT>
</DOCUMENT>